Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

ARV Tender Suffers a Blow as High Court Sets Aside Contracts

The High Court set aside R12.6bn in TLD contracts in the ARV tender, ordering Cipla’s inclusion and excluding Viatris and Innovata.
ARV Tender Suffers a Blow as High Court Sets Aside Contracts
Image | Gam1983 | iStock/1181839849

The High Court in Pretoria has declared the main contracts in the Health Department's R15.5 billion ARV tender unconstitutional and invalid. The court set aside two contracts for monthly and three-monthly packs of tenofovir, lamivudine and dolutegravir (TLD), worth a combined R12.63 billion.

TLD is the triple combination pill taken by most of South Africa's HIV-positive patients. According to Treasury, an estimated 8 million people live with HIV, of whom 5.7 million are on treatment.

Continue reading with a Health Matters subscription

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in

More from Health Matters

23.10.2026

Experts warn that opioid overprescribing after minor surgery risks addiction and waste, and paracetamol and NSAIDs often suffice.

23.10.2026

Clicks annual results show turnover topping R50bn, while UPD faced margin pressure from the smaller medicine price increase.